Domain Therapeutics
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Domain Therapeutics?
Domain Therapeutics is a French Biotech company, currently owned by Turenne Groupe since 2022.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Turenne GroupeCapital Santé 2 · 2020 · Growth
2 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2015 · present
Capital Grand EstExited
2015 · Cap Innov'Est 1 · 2014 · VC
Capital Grand Est exited Domain Therapeutics.
Turenne GroupeActive
2022 · present(4yr) · Capital Santé 2 · 2020 · Growth
More from Capital Santé 2
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Domain Therapeutics?
Domain Therapeutics is currently owned by Turenne Groupe, through Capital Santé 2, since 2022.
When did Turenne Groupe acquire Domain Therapeutics?
Turenne Groupe acquired Domain Therapeutics in 2022.
Who has owned Domain Therapeutics over time?
Domain Therapeutics has been through 2 private-equity ownership periods: Capital Grand Est · via Cap Innov'Est 1 · since 2015; Turenne Groupe · via Capital Santé 2 · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue